Pfizer/Boehringer Ingelheim’s Spiriva Linked To Stroke In FDA MedWatch Alert

Pooled analyses of data on COPD treatment show increased risk of stroke in two patients per 1,000, agency says.

More from Archive

More from Pink Sheet